相似文献
1
Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus.
An Bras Dermatol. 2018 Jun;93(3):469-470. doi: 10.1590/abd1806-4841.20187615.
2
Hydroxychloroquine-induced ototoxicity in a child with systemic lupus erythematosus.
Int J Rheum Dis. 2011 Feb;14(1):e1-2. doi: 10.1111/j.1756-185X.2010.01582.x.
3
Ototoxicity due to hydroxychloroquine: report of two cases.
Clin Exp Rheumatol. 1998 Jul-Aug;16(4):472-4.
4
Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Laryngoscope. 2021 Mar;131(3):E957-E960. doi: 10.1002/lary.28873. Epub 2020 Jun 30.
5
Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
Am J Otolaryngol. 2021 Sep-Oct;42(5):102640. doi: 10.1016/j.amjoto.2020.102640. Epub 2020 Jul 8.
6
Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Reumatol Clin. 2017 Sep-Oct;13(5):294-296. doi: 10.1016/j.reuma.2016.04.008. Epub 2016 Jun 2.
7
Nonlupus nephritis in an adolescent with systemic lupus erythematosus.
Lupus. 2005;14(2):171-3. doi: 10.1191/0961203305lu2077xx.
8
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.
Rheumatol Int. 2000 Dec;20(1):31-3. doi: 10.1007/s002960000066.
9
Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis.
Int J Pediatr Otorhinolaryngol. 2002 Jan 11;62(1):53-7. doi: 10.1016/s0165-5876(01)00592-4.
10
Auditory Cinchonism in COVID Era.
Ear Nose Throat J. 2020 Nov;99(9):597-598. doi: 10.1177/0145561320947255. Epub 2020 Aug 3.
引用本文的文献
1
Prevalence and determinants of hearing loss in systemic lupus erythematosus: A cross-sectional study in a tertiary care center in Saudi Arabia.
Saudi Med J. 2025 Jul;46(7):788-796. doi: 10.15537/smj.2025.46.7.20241075.
2
Audiovestibular Dysfunction in Systemic Lupus Erythematosus Patients: A Systematic Review.
Diagnostics (Basel). 2024 Aug 1;14(15):1670. doi: 10.3390/diagnostics14151670.
3
The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review.
Int Arch Otorhinolaryngol. 2022 Jan 25;26(1):e167-e177. doi: 10.1055/s-0041-1740986. eCollection 2022 Jan.
4
Auditive and Vestibular Changes Related to the Use of Hydroxychlorochine and Chlorochine: An Integrative Review.
Int Arch Otorhinolaryngol. 2021 Apr;25(2):e309-e317. doi: 10.1055/s-0040-1722292. Epub 2021 Mar 29.
5
Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.
Front Pharmacol. 2021 Apr 12;12:576093. doi: 10.3389/fphar.2021.576093. eCollection 2021.
6
Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
Am J Otolaryngol. 2021 Sep-Oct;42(5):102640. doi: 10.1016/j.amjoto.2020.102640. Epub 2020 Jul 8.
7
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
8
Chloroquine and COVID-19: Should We Care about Ototoxicity?
Int Arch Otorhinolaryngol. 2020 Jul;24(3):e359-e363. doi: 10.1055/s-0040-1714142. Epub 2020 Jul 31.
9
Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Laryngoscope. 2021 Mar;131(3):E957-E960. doi: 10.1002/lary.28873. Epub 2020 Jun 30.
10
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Front Public Health. 2020 May 29;8:252. doi: 10.3389/fpubh.2020.00252. eCollection 2020.
本文引用的文献
1
Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance Network.
Ann Rheum Dis. 2012 Sep;71(9):1586. doi: 10.1136/annrheumdis-2011-201265. Epub 2012 Apr 13.
2
Chloroquine ototoxicity.
Clin Rheumatol. 2007 Nov;26(11):1809-10. doi: 10.1007/s10067-007-0662-6. Epub 2007 Jun 27.
3
Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
Rheumatol Int. 2000;19(5):203-4. doi: 10.1007/s002960000054.
Zotero 插件